COMBINAISONS ET RÉGIMES POSOLOGIQUES POUR TRAITER DES TUMEURS RB-POSITIVES

• 收藏
• 分享

专利权人:

G1 Therapeutics; Inc.

发明人:

申请号：

EP15840655.3

公开号：

EP3191098A4

申请日:

2015.09.11

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

This invention directed to methods for treating select RB-positive cancers and other Rb-positive abnormal cellular proliferative disorders using CDK4/6 inhibitors in specific dosing and combination or alternation regimes. In one aspect, treatments of select RB-positive cancers are disclosed using specific CDK4/6 inhibitors in combination or alternation with another chemotherapeutic, for example, an additional kinase inhibitor, PD-1 inhibitor, or BCL-2 inhibitor, or combination thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/